Page last updated: 2024-11-03

probenecid and Endometritis

probenecid has been researched along with Endometritis in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Endometritis: Inflammation of the ENDOMETRIUM, usually caused by intrauterine infections. Endometritis is the most common cause of postpartum fever.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haggerty, CL1
Ness, RB1
Amortegui, A1
Hendrix, SL1
Hillier, SL1
Holley, RL1
Peipert, J1
Randall, H1
Sondheimer, SJ1
Soper, DE1
Sweet, RL1
Trucco, G1

Trials

1 trial available for probenecid and Endometritis

ArticleYear
Endometritis does not predict reproductive morbidity after pelvic inflammatory disease.
    American journal of obstetrics and gynecology, 2003, Volume: 188, Issue:1

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Cefoxitin; Chla

2003